{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:18:30Z","timestamp":1792189110278,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,6]],"date-time":"2027-04-06T00:00:00Z","timestamp":1806969600000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS097197"],"award-info":[{"award-number":["P01NS097197"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376430"],"award-info":[{"award-number":["PNRR-MR1-2022-12376430"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013405","name":"Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010805","name":"Tatiana P\u00e9rez de Guzm\u00e1n el Bueno Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pneurobio.2026.102912","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:42:13Z","timestamp":1775230933000},"page":"102912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epm2bP71A and Epm2bD148N knock-in mouse models of Lafora disease exhibit distinct and pronounced neurological alterations"],"prefix":"10.1016","volume":"261","author":[{"given":"Nerea","family":"Iglesias-Cabeza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Zafra-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Worby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fern\u00e1ndez-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sciaccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Fermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"S\u00e1nchez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Serratosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-7680","authenticated-orcid":false,"given":"Marina P.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2026.102912_bib1","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","article-title":"Laforin, the most common protein mutated in Lafora disease, regulates autophagy","volume":"19","author":"Aguado","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1552-6569.2008.00325.x","article-title":"MR spectroscopy findings in Lafora disease: short communication","volume":"19","author":"Altindag","year":"2009","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.pneurobio.2026.102912_bib3","unstructured":"ARRIVE guidelines | NC3Rs [WWW Document], n.d. URL \u3008https:\/\/nc3rs.org.uk\/arrive-guidelines\u3009 (accessed 4.22.25)."},{"key":"10.1016\/j.pneurobio.2026.102912_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5357\/koubyou.60.264","article-title":"Production of monoclonal antibody that recognizes glycogen and its application for immunohistochemistry","volume":"60","author":"Baba","year":"1993","journal-title":"Kokubyo Gakkai Zasshi"},{"key":"10.1016\/j.pneurobio.2026.102912_bib5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1528-1167.2005.00272.x","article-title":"Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation","volume":"46","author":"Baykan","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pneurobio.2026.102912_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM198607313150506","article-title":"Progressive myoclonus epilepsies: specific causes and diagnosis","volume":"315","author":"Berkovic","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2026.102912_bib7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12035-015-9091-8","article-title":"Pharmacological interventions to ameliorate neuropathological symptoms in a mouse model of lafora disease","volume":"53","author":"Berthier","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70050","article-title":"A Comparative analysis of grip strength evaluation methods in a large cohort of aged mice","volume":"16","author":"Bigossi","year":"2025","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.pneurobio.2026.102912_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-019-1132-3","article-title":"Treatment with metformin in twelve patients with Lafora disease","volume":"14","author":"Bisulli","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2026.102912_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/9780470942390.mo110165","article-title":"Assessment of motor coordination and balance in mice using the rotarod, elevated bridge, and footprint tests","volume":"2","author":"Brooks","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-9994-12-S1-S17","article-title":"Lifetime development of behavioural phenotype in the house mouse (Mus musculus)","volume":"12","author":"Brust","year":"2015","journal-title":"Front. Zool."},{"key":"10.1016\/j.pneurobio.2026.102912_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21207771","article-title":"Structural and functional brain abnormalities in mouse models of lafora disease","volume":"21","author":"Burgos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib13","article-title":"Early treatment with metformin improves neurological outcomes in lafora disease","author":"Burgos","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2026.102912_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106119","article-title":"Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a\u2212\/\u2212 mice","volume":"181","author":"Burgos","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2026.102912_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","article-title":"Mutations in NHLRC1 cause progressive myoclonus epilepsy","volume":"35","author":"Chan","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jmg.40.9.671","article-title":"Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2b) on 6p22","volume":"40","author":"Chan","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib17","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1101\/gad.1553207","article-title":"A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori\u2019s disease","volume":"21","author":"Cheng","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.pneurobio.2026.102912_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00109-011-0758-y","article-title":"Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism","volume":"89","author":"Couarch","year":"2011","journal-title":"J. Mol. Med. (Berl. )."},{"key":"10.1016\/j.pneurobio.2026.102912_bib19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","article-title":"Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy","volume":"21","author":"Criado","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib20","article-title":"Electro-clinical features and management of the late stage of Lafora disease","volume":"13","author":"d\u2019Orsi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib21","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","article-title":"Genetic depletion of the malin e3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin","volume":"285","author":"DePaoli-Roach","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib22","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.01.130","article-title":"The E3 ligase malin plays a pivotal role in promoting nuclear glycogenolysis and histone acetylation","volume":"8","author":"Donohue","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.pneurobio.2026.102912_bib23","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","author":"Duran","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.pneurobio.2026.102912_bib24","first-page":"2360","article-title":"Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease","volume":"2349","author":"Duran","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2026.102912_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/ilar.43.2.66","article-title":"The mousetrap: what we can learn when the mouse model does not mimic the human disease","volume":"43","author":"Elsea","year":"2002","journal-title":"ILAR J."},{"key":"10.1016\/j.pneurobio.2026.102912_bib26","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddg340","article-title":"Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation","volume":"12","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib27","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/oxfordjournals.hmg.a018916","article-title":"Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes","volume":"9","author":"Ganesh","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","article-title":"Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice","volume":"11","author":"Ganesh","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/11.11.1263","article-title":"Genotype-phenotype correlations for EPM2A mutations in Lafora\u2019s progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype","volume":"11","author":"Ganesh","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/NEN.0b013e318253350f","article-title":"Laforin and malin deletions in mice produce similar neurologic impairments","volume":"71","author":"Garc\u00eda-Cabrero","year":"2012","journal-title":"J. Neuropathol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib31","first-page":"1","article-title":"Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole","volume":"8","author":"Garc\u00eda-Cabrero","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells7080087","article-title":"Lafora disease: a ubiquitination-related pathology","volume":"7","author":"Garc\u00eda-Gimeno","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.pneurobio.2026.102912_bib33","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","article-title":"Insights into Lafora disease: Malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin","volume":"102","author":"Gentry","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2026.102912_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","article-title":"Lafora disease due to EPM2B mutations","volume":"64","author":"G\u00f3mez-Abad","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2026.102912_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-biochem-061516-044518","article-title":"Protein misfolding diseases","volume":"86","author":"Hartl","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib36","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1016\/S0021-9258(20)82050-X","article-title":"Components of ubiquitin-protein ligase system","volume":"258","author":"Hershko","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00702-008-0157-x","article-title":"Increased EEG power density in alpha and theta bands in adult ADHD patients","volume":"116","author":"Koehler","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.pneurobio.2026.102912_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-410513-3.00009-7","article-title":"Beta and gamma rhythms","author":"Kropotov","year":"2016","journal-title":"Funct. Neuroma Psychiatry"},{"key":"10.1016\/j.pneurobio.2026.102912_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF01989438","article-title":"\u00dcber das Vorkommen amyloider K\u00f6rperchen im Innern der Ganglienzellen - zugleich Ein Beitrag zum Studium der amyloiden Substanz im Nervensystem","volume":"205","author":"Lafora","year":"1911","journal-title":"Virchows Arch. path Anat."},{"key":"10.1016\/j.pneurobio.2026.102912_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02863929","article-title":"Beitrag zur Histopathologie der myoklonischen Epilepsie","volume":"6","author":"Lafora","year":"1911","journal-title":"Z. F. \u00fcR. die Gesamt Neurol. und Psychiatr."},{"key":"10.1016\/j.pneurobio.2026.102912_bib41","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s12035-019-01842-z","article-title":"Reactive glia-derived neuroinflammation, a novel hallmark in Lafora progressive myoclonus epilepsy that progresses with age","volume":"57","author":"Lahuerta","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddy323","article-title":"Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses","volume":"28","author":"Medina-Carmona","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cpmo.12","article-title":"Histomorphological Phenotyping of the Adult Mouse Brain","volume":"6","author":"Mikhaleva","year":"2016","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","article-title":"Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy","volume":"20","author":"Minassian","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib45","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s12035-021-02285-1","article-title":"Modulators of neuroinflammation have a beneficial effect in a lafora disease mouse model","volume":"58","author":"Moll\u00e1","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib46","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1007\/s12035-022-02956-7","article-title":"Pharmacological modulation of glutamatergic and neuroinflammatory pathways in a lafora disease mouse model","volume":"59","author":"Moll\u00e1","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112959","article-title":"vivo glutamate clearance defects in a mouse model of Lafora disease","volume":"320","author":"Mu\u00f1oz-Ballester","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib48","first-page":"1","article-title":"EEG normal waveforms","author":"Nayak","year":"2023","journal-title":"StatPearls"},{"key":"10.1016\/j.pneurobio.2026.102912_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042317","article-title":"Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1)","volume":"7","author":"Naylor","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2026.102912_bib50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12035-012-8265-x","article-title":"Aberrant dendritic excitability: a common pathophysiology in CNS disorders affecting memory?","volume":"45","author":"Nestor","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/02611929221099165","article-title":"The rise of three Rs centres and platforms in Europe","volume":"50","author":"Neuhaus","year":"2022","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.pneurobio.2026.102912_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fnhum.2018.00521","article-title":"EEG Frequency bands in psychiatric disorders: a review of resting state studies","volume":"12","author":"Newson","year":"2019","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-7-7","article-title":"Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease","volume":"7","author":"Ortolano","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.pneurobio.2026.102912_bib54","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/glia.23956","article-title":"Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: implications in Lafora disease","volume":"69","author":"Perez-Jimenez","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2026.102912_bib55","article-title":"Mouse models of human disease: an evolutionary perspective","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health 2016 170."},{"key":"10.1016\/j.pneurobio.2026.102912_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01989-w","article-title":"Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis","volume":"16","author":"Pondrelli","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2026.102912_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-023-02880-6","article-title":"Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data","volume":"18","author":"Pondrelli","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2026.102912_bib58","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1093\/hmg\/ddq407","article-title":"Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin","volume":"19","author":"Rao","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117409","article-title":"Italian cohort of Lafora disease: clinical features, disease evolution, and genotype-phenotype correlations","volume":"424","author":"Riva","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib60","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/iub.1072","article-title":"Deciphering the role of malin in the Lafora progressive myoclonus epilepsy","volume":"64","author":"Rom\u00e1-Mateo","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pneurobio.2026.102912_bib61","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.freeradbiomed.2014.10.809","article-title":"Increased oxidative stress and impaired antioxidant response in Lafora disease","volume":"75","author":"Rom\u00e1-Mateo","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2026.102912_bib62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s12035-014-8747-0","article-title":"Increased oxidative stress and impaired antioxidant response in lafora disease","volume":"51","author":"Rom\u00e1-Mateo","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105964","article-title":"TNF and IL6\/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy","volume":"176","author":"Rubio","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2026.102912_bib64","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddy044","article-title":"Astrocytes: new players in progressive myoclonus epilepsy of Lafora type","volume":"27","author":"Rubio-Villena","year":"2018","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.pneurobio.2026.102912_bib65","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuron.2011.05.012","article-title":"Pattern separation: a common function for new neurons in hippocampus and olfactory bulb","volume":"70","author":"Sahay","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2026.102912_bib66","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/hmg\/4.9.1657","article-title":"The gene for progressive myoclonus epilepsy of the lafora type maps to chromosome 6q","volume":"4","author":"Serratosa","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","article-title":"A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2","volume":"8","author":"Serratosa","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib68","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050905","article-title":"Neuromuscular junction dysfunction in Lafora disease","volume":"17","author":"Shukla","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.pneurobio.2026.102912_bib69","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/MCB.06353-11","article-title":"The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters","volume":"32","author":"Singh","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib70","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1091\/mbc.e13-05-0261","article-title":"Activation of serum\/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease","volume":"24","author":"Singh","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pneurobio.2026.102912_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/ddm339","article-title":"Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway","volume":"17","author":"Solaz-Fuster","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2026.102912_bib72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cmet.2019.08.014","article-title":"Nuclear glycogenolysis modulates histone acetylation in human non-small cell lung cancers","volume":"30","author":"Sun","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.pneurobio.2026.102912_bib73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cmet.2019.08.014","article-title":"Nuclear glycogenolysis modulates histone acetylation in human non-small cell lung cancers","volume":"30","author":"Sun","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.pneurobio.2026.102912_bib74","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ana.22156","article-title":"Glycogen hyperphosphorylation underlies Lafora body formation","volume":"68","author":"Turnbull","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib75","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/emmm.201100174","article-title":"Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease","volume":"3","author":"Valles-Ortega","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pneurobio.2026.102912_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005907","article-title":"Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin","volume":"4","author":"Vernia","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2026.102912_bib77","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1074\/jbc.M808492200","article-title":"AMP-activated protein kinase phosphorylates R5\/PTG, the glycogen targeting subunit of the R5\/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex","volume":"284","author":"Vernia","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib78","article-title":"Glial alterations in the glutamatergic and GABAergic signaling pathways in a mouse model of Lafora disease, a severe form of progressive myoclonus epilepsy","author":"Viana","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.pneurobio.2026.102912_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/nan.70009","article-title":"Glial alterations in the glutamatergic and GABAergic signalling pathways in a mouse model of lafora disease, a severe form of progressive myoclonus epilepsy","volume":"51","author":"Viana","year":"2025","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib80","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn1998","article-title":"Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy","volume":"10","author":"Vilchez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib81","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1167.2006.00526.x","article-title":"MRI volumetry and proton MR spectroscopy of the brain in Lafora disease","volume":"47","author":"Villanueva","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.pneurobio.2026.102912_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.74.1.51","article-title":"Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy","author":"Willoughby","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2026.102912_bib83","doi-asserted-by":"crossref","first-page":"30412","DOI":"10.1074\/jbc.M606117200","article-title":"Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates","volume":"281","author":"Worby","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib84","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1074\/jbc.M708712200","article-title":"Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)","volume":"283","author":"Worby","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2026.102912_bib85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/bmm.11.74","article-title":"High-frequency oscillations and other electrophysiological biomarkers of epilepsy: clinical studies","volume":"5","author":"Worrell","year":"2011","journal-title":"Biomark. Med."},{"key":"10.1016\/j.pneurobio.2026.102912_bib86","first-page":"466","article-title":"Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases","volume":"30","author":"Yokoi","year":"1968","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-319-63904-8_4","article-title":"A transgenic core facility\u2019s experience in genome editing revolution","volume":"1016","author":"Yuan","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pneurobio.2026.102912_bib88","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ymthe.2024.05.032","article-title":"Gene therapy for Lafora disease in the Epm2a\u2212\/\u2212 mouse model","volume":"32","author":"Zafra-Puerta","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pneurobio.2026.102912_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411930","article-title":"Adeno-associated virus-based gene therapy for lafora disease in Epm2b-deficient mice","volume":"26","author":"Zafra-Puerta","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2026.102912_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70514","article-title":"Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes","volume":"15","author":"Zafra-Puerta","year":"2025","journal-title":"Clin. Transl. Med."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008226000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008226000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:33:42Z","timestamp":1779190422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008226000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":90,"alternative-id":["S0301008226000389"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2026.102912","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epm2bP71A and Epm2bD148N knock-in mouse models of Lafora disease exhibit distinct and pronounced neurological alterations","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2026.102912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102912"}}